Literature DB >> 25518927

Are macrophages in tumors good targets for novel therapeutic approaches?

Samthosh V Alahari1, Shengli Dong1, Suresh K Alahari1.   

Abstract

The development of cancer has been an extensively researched topic over the past few decades. Although great strides have been made in cancer prevention, diagnosis, and treatment, there is still much to be learned about cancer's micro-environmental mechanisms that contribute to cancer formation and aggressiveness. Macrophages, lymphocytes which originate from monocytes, are involved in the inflammatory response and often dispersed to areas of infection to fight harmful antigens and mutated cells in tissues. Macrophages have a plethora of roles including tissue development and repair, immune system functions, and inflammation. We discuss various pathways by which macrophages get activated, various approaches that can regulate the function of macrophages, and how these approaches can be helpful in developing new cancer therapies.

Entities:  

Keywords:  angiogenesis; cancer; invasion; macrophages; microenvironment; migration

Mesh:

Substances:

Year:  2014        PMID: 25518927      PMCID: PMC4332036          DOI: 10.14348/molcells.2015.2298

Source DB:  PubMed          Journal:  Mol Cells        ISSN: 1016-8478            Impact factor:   5.034


  131 in total

1.  p19ARF targets certain E2F species for degradation.

Authors:  F Martelli; T Hamilton; D P Silver; N E Sharpless; N Bardeesy; M Rokas; R A DePinho; D M Livingston; S R Grossman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-03-27       Impact factor: 11.205

2.  Bisphosphonates induce breast cancer cell death in vitro.

Authors:  O Fromigue; L Lagneaux; J J Body
Journal:  J Bone Miner Res       Date:  2000-11       Impact factor: 6.741

Review 3.  Proteases in invasion: matrix metalloproteinases.

Authors:  W G Stetler-Stevenson; A E Yu
Journal:  Semin Cancer Biol       Date:  2001-04       Impact factor: 15.707

Review 4.  Bisphosphonates: mechanisms of action.

Authors:  G A Rodan; H A Fleisch
Journal:  J Clin Invest       Date:  1996-06-15       Impact factor: 14.808

5.  Chemotherapy alters monocyte differentiation to favor generation of cancer-supporting M2 macrophages in the tumor microenvironment.

Authors:  Eveline M Dijkgraaf; Moniek Heusinkveld; Bart Tummers; Lisa T C Vogelpoel; Renske Goedemans; Veena Jha; Johan W R Nortier; Marij J P Welters; Judith R Kroep; Sjoerd H van der Burg
Journal:  Cancer Res       Date:  2013-02-22       Impact factor: 12.701

Review 6.  Interleukin-10 and the interleukin-10 receptor.

Authors:  K W Moore; R de Waal Malefyt; R L Coffman; A O'Garra
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

7.  Macrophage arginase promotes tumor cell growth and suppresses nitric oxide-mediated tumor cytotoxicity.

Authors:  C I Chang; J C Liao; L Kuo
Journal:  Cancer Res       Date:  2001-02-01       Impact factor: 12.701

8.  Potential involvement of IL-10 in suppressing tumor-associated macrophages. Colon-26-derived prostaglandin E2 inhibits TNF-alpha release via a mechanism involving IL-10.

Authors:  T Kambayashi; H R Alexander; M Fong; G Strassmann
Journal:  J Immunol       Date:  1995-04-01       Impact factor: 5.422

9.  IL-10 production in cutaneous basal and squamous cell carcinomas. A mechanism for evading the local T cell immune response.

Authors:  J Kim; R L Modlin; R L Moy; S M Dubinett; T McHugh; B J Nickoloff; K Uyemura
Journal:  J Immunol       Date:  1995-08-15       Impact factor: 5.422

10.  Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype.

Authors:  Thorsten Hagemann; Julia Wilson; Frances Burke; Hagen Kulbe; Ninfeng Fiona Li; Annette Plüddemann; Kellie Charles; Siamon Gordon; Frances R Balkwill
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

View more
  4 in total

1.  Cell-Based IL-15:IL-15Rα Secreting Vaccine as an Effective Therapy for CT26 Colon Cancer in Mice.

Authors:  Van Anh Do Thi; Hyung Min Jeon; Sang Min Park; Hayyoung Lee; Young Sang Kim
Journal:  Mol Cells       Date:  2019-12-31       Impact factor: 5.034

2.  lncRNA-Xist/miR-101-3p/KLF6/C/EBPα axis promotes TAM polarization to regulate cancer cell proliferation and migration.

Authors:  Yanyun Zhao; Zhaojin Yu; Rong Ma; Yifan Zhang; Lin Zhao; Yuanyuan Yan; Xuemei Lv; Liwen Zhang; Panpan Su; Jia Bi; Hong Xu; Miao He; Minjie Wei
Journal:  Mol Ther Nucleic Acids       Date:  2020-12-10       Impact factor: 8.886

Review 3.  Crosstalk Among YAP, LncRNA, and Tumor-Associated Macrophages in Tumorigenesis Development.

Authors:  Jing Xu; Xin-Yuan Liu; Qi Zhang; Hua Liu; Peng Zhang; Zi-Bin Tian; Cui-Ping Zhang; Xiao-Yu Li
Journal:  Front Oncol       Date:  2022-01-06       Impact factor: 6.244

4.  The role of S100A9 in the interaction between pancreatic ductal adenocarcinoma cells and stromal cells.

Authors:  Pin-Jui Kung; Ting-Yu Lai; Jerry Cao; Li-Chung Hsu; Tsai-Chen Chiang; Pu Ou-Yang; Ching-Yi Tsai; Yi-Fen Tsai; Chih-Wen Lin; Chien-Chia Chen; Meng-Kun Tsai; Yu-Wen Tien; Chih-Yuan Lee
Journal:  Cancer Immunol Immunother       Date:  2021-08-10       Impact factor: 6.968

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.